Mirion Technologies, Inc. (MIR)
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Sector: Measuring & Controlling Devices, NEC
Industry: Industrial - Machinery
Mirion Technologies, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 249.04M shares outstanding
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia.
The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring.
Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries.
It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Leadership
Alison Ulrich
Chief Human Resources Officer
Brian Schopfer
CFO & Medical Group President
Emmanuelle Lee
Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary
Loic Eloy
Group President of Nuclear & Safety Technologies
Employees
3K+
Country
US
Sector
Industrials
Website
mirion.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chief Financial Officer | Purchase | 20.0K | $312.0K | Sep 2, 2026 | |
| Director | Grant/Award | 7.4K | -- | May 13, 2026 | |
| Director | Grant/Award | 7.4K | -- | May 13, 2026 | |
| Director | Grant/Award | 7.4K | -- | May 13, 2026 | |
| Director | Grant/Award | 7.4K | -- | May 13, 2026 | |
| Director | Grant/Award | 7.4K | -- | May 13, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 38.3M | 15.4% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Oct 2025 | 35.7M | 14.3% | 13G |
VANGUARD PORTFOLIO MANAGEMENT LLC | 18.2M | 7.3% | 13F |
T. Rowe Price Investment Management, Inc. | 14.3M | 5.7% | 13F |
The Goldman Sachs Group, Inc. · also on 13F· may incl. warrants· filed Nov 2024 | 12.4M | 5.0% | 13D |
VANGUARD CAPITAL MANAGEMENT LLC | 10.6M | 4.3% | 13F |
GOLDMAN SACHS GROUP INC | 10.4M | 4.2% | 13F |
STATE STREET CORP | 9.9M | 4.0% | 13F |
Alyeska Investment Group, L.P. | 9.5M | 3.8% | 13F |
Janus Henderson Group plc EIN #00-0000000 · may incl. warrants· stale · filed Feb 2024 | 9.4M | 3.8% | 13G |
Insiders
- Schopfer BrianChief Financial Officer
- Bockhorst KennethDirector
- Kingsley Lawrence DDirector
- Rege SheilaDirector
- Markopoulos JodyDirector
- KUO JOHN WDirector
- Etzel Steven W.Director
- CASCELLA ROBERTDirector
- Moore Christopher A.Chief Accounting Officer (PAO)
- Logan Thomas DChief Executive Officer
based on 249.04M shares outstanding
30d Avg
4.13M
60d Avg
3.96M
90d Avg
4.01M